Adiponectin and Cardiovascular Disease

被引：173

作者：

Shibata, Rei ^{[1
]}

Ouchi, Noriyuki ^{[2
]}

Murohara, Toyoaki

机构：

[1] Nagoya Univ, Dept Cardiol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan

[2] Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, Boston, MA 02118 USA

来源：

CIRCULATION JOURNAL | 2009年 / 73卷 / 04期

关键词：

Adiponectin; Cardiovascular disease; Obesity; CORONARY-HEART-DISEASE; ACTIVATED PROTEIN-KINASE; VENTRICULAR DIASTOLIC FUNCTION; ISCHEMIA-REPERFUSION INJURY; IMPAIRED GLUCOSE-TOLERANCE; ADIPOSE-SPECIFIC PROTEIN; MOLECULAR-WEIGHT FORM; BODY-MASS INDEX; INSULIN-RESISTANCE; PLASMA ADIPONECTIN;

D O I：

10.1253/circj.CJ-09-0057

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Obesity is strongly associated with metabolic and cardiovascular disorders. Adiponectin is an adipose-derived plasma protein that is downregulated in subjects with obesity-related disorders. Low levels of adiponectin are associated with the increased prevalence of obesity-linked cardiovascular diseases, including ischemic heart disease and peripheral artery disease. Experimental findings have shown that adiponectin has beneficial effects in the cardiovascular system by directly acting on the component cells of the heart and blood vessels. Adiponectin protects cardiovascular tissues under conditions of stress through a number of mechanisms: inhibition of pro-inflammatory and hypertrophic responses, and stimulation of endothelial cell responses. These effects of adiponectin are mainly attributed to the modulation of signaling molecules, including AMP-activated protein kinase. Thus, adiponectin could be a promising therapeutic target for cardiovascular diseases. (Circ J 2009;73: 608-614)

引用

页码：608 / 614

页数：7

共 97 条

[1] Insights into the pathogenesis of chronic heart failure: immune activation and cachexia [J].

Anker, SD ;

Rauchhaus, M .

CURRENT OPINION IN CARDIOLOGY, 1999, 14 (03) :211-216

[2] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].

Arita, Y ;

Kihara, S ;

Ouchi, N ;

Takahashi, M ;

Maeda, K ;

Miyagawa, J ;

Hotta, K ;

Shimomura, I ;

Nakamura, T ;

Miyaoka, K ;

Kuriyama, H ;

Nishida, M ;

Yamashita, S ;

Okubo, K ;

Matsubara, K ;

Muraguchi, M ;

Ohmoto, Y ;

Funahashi, T ;

Matsuzawa, Y .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83

[3] Peroxisome proliferator-activated receptor γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo [J].

Asakawa, M ;

Takano, H ;

Nagai, T ;

Uozumi, H ;

Hasegawa, H ;

Kubota, N ;

Saito, T ;

Masuda, Y ;

Kadowaki, T ;

Komuro, I .

CIRCULATION, 2002, 105 (10) :1240-1246

[4] Adiponectin stimulates production of nitric oxide in vascular endothelial cells [J].

Chen, H ;

Montagnani, M ;

Funahashi, T ;

Shimomura, I ;

Quon, MJ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :45021-45026

[5] Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells [J].

Cheng, Kenneth K. Y. ;

Lam, Karen S. L. ;

Wang, Yu ;

Huang, Yu ;

Carling, David ;

Wu, Donghai ;

Wong, Chiwai ;

Xu, Aimin .

DIABETES, 2007, 56 (05) :1387-1394

[6] Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex [J].

Cnop, M ;

Havel, PJ ;

Utzschneider, KM ;

Carr, DB ;

Sinha, MK ;

Boyko, EJ ;

Retzlaff, BM ;

Knopp, RH ;

Brunzell, JD ;

Kahn, SE .

DIABETOLOGIA, 2003, 46 (04) :459-469

[7] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[8] Impact of adiponectin on left ventricular mass index in non-complicated obese subjects [J].

Ebinc, Haksun ;

Ebninc, Fatma Ayerden ;

Oezkurt, Zuebeyde Nur ;

Dogru, Mehmet Tolga ;

Tulmac, Murat ;

Yilmaz, Murat ;

Caglayan, Osman .

ENDOCRINE JOURNAL, 2008, 55 (03) :523-528

[9] A war on obesity, not the obese [J].

Friedman, JM .

SCIENCE, 2003, 299 (5608) :856-858

[10] Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice [J].

Fruebis, J ;

Tsao, TS ;

Javorschi, S ;

Ebbets-Reed, D ;

Erickson, MRS ;

Yen, FT ;

Bihain, BE ;

Lodish, HF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :2005-2010

← 1 2 3 4 5 6 7 8 9 10 →